The company agreed to settle a lawsuit alleging it improperly billed government health plans for its genetic tests.
Dominion Diagnostics will pay $815,000 to settle allegations by the US Attorney's Office and Vermont that it improperly billed for tests.
The settlement requires that Curiox refrain from saying that one of its products has equivalent or better sensitivity and reproducibility than a Luminex system.
The deal ends an investigation by the SEC into certain accounting practices by Alere's foreign subsidiaries. The company also consented to a cease-and-desist order.
In separate deals, Poplar Healthcare will pay the federal government nearly $900,000, while Piedmont Pathology will pay $601,000.
Partner Fund Management sued Theranos, saying the blood testing firm had deceived it into investing $96.1 million. Theranos is in the midst of a tender offer.
Theranos was fined $30,000 by CMS. Meanwhile, it will pay $4.65 million to Arizona residents for blood testing services that it performed between 2013 and 2016.
NEW YORK (GenomeWeb News) – Cepheid said after the close of the market Tuesday that it has reached a settlement with Abaxis over litigation the firms had filed against each other a couple of yeasr ago.